Brian M Fuller1, Nicholas M Mohr2, Anne M Drewry3, Ian T Ferguson4, Stephen Trzeciak5, Marin H Kollef6, Brian W Roberts7. 1. Departments of Emergency Medicine and Anesthesiology, Division of Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, United States. Electronic address: fullerb@wustl.edu. 2. Departments of Emergency Medicine and Anesthesiology, Division of Critical Care Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 200 Hawkins Drive, 1008 RCP, Iowa City, IA 52242, United States. Electronic address: nicholas-mohr@uiowa.edu. 3. Department of Anesthesiology, Division of Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, United States. Electronic address: drewrya@wustl.edu. 4. School of Medicine and Medical Science, University College Dublin, Dublin 4, Ireland. Electronic address: ian.ferguson@ucdconnect.ie. 5. Departments of Medicine and Emergency Medicine, Division of Critical Care Medicine, Cooper University Hospital, One Cooper Plaza, K152, Camden, NJ 08103, United States. Electronic address: Trzeciak-Stephen@cooperhealth.edu. 6. Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, United States. Electronic address: mkollef@dom.wustl.edu. 7. Department of Emergency Medicine, Cooper University Hospital, One Cooper Plaza, K152, Camden, NJ 08103, United States. Electronic address: roberts-brian-w@cooperhealth.edu.
Abstract
PURPOSE: To describe the prevalence of hypocapnia and hypercapnia during the earliest period of mechanical ventilation, and determine the association between PaCO2 and mortality. MATERIALS AND METHODS: A cohort study using an emergency department registry of mechanically ventilated patients. PaCO2 was categorized: hypocapnia (<35mmHg), normocapnia (35-45mmHg), and hypercapnia (>45mmHg). The primary outcome was survival to hospital discharge. RESULTS: A total of 1,491 patients were included. Hypocapnia occurred in 375 (25%) patients and hypercapnia in 569 (38%). Hypercapnia (85%) had higher survival rate compared to normocapnia (74%) and hypocapnia (66%), P<0.001. PaCO2 was an independent predictor of survival to hospital discharge [hypocapnia (aOR 0.65 (95% confidence interval [CI] 0.48-0.89), normocapnia (reference category), hypercapnia (aOR 1.83 (95% CI 1.32-2.54)]. Over ascending ranges of PaCO2, there was a linear trend of increasing survival up to a PaCO2 range of 66-75mmHg, which had the strongest survival association, aOR 3.18 (95% CI 1.35-7.50). CONCLUSIONS: Hypocapnia and hypercapnia occurred frequently after initiation of mechanical ventilation. Higher PaCO2 levels were associated with increased survival. These data provide rationale for a trial examining the optimal PaCO2 in the critically ill.
PURPOSE: To describe the prevalence of hypocapnia and hypercapnia during the earliest period of mechanical ventilation, and determine the association between PaCO2 and mortality. MATERIALS AND METHODS: A cohort study using an emergency department registry of mechanically ventilated patients. PaCO2 was categorized: hypocapnia (<35mmHg), normocapnia (35-45mmHg), and hypercapnia (>45mmHg). The primary outcome was survival to hospital discharge. RESULTS: A total of 1,491 patients were included. Hypocapnia occurred in 375 (25%) patients and hypercapnia in 569 (38%). Hypercapnia (85%) had higher survival rate compared to normocapnia (74%) and hypocapnia (66%), P<0.001. PaCO2 was an independent predictor of survival to hospital discharge [hypocapnia (aOR 0.65 (95% confidence interval [CI] 0.48-0.89), normocapnia (reference category), hypercapnia (aOR 1.83 (95% CI 1.32-2.54)]. Over ascending ranges of PaCO2, there was a linear trend of increasing survival up to a PaCO2 range of 66-75mmHg, which had the strongest survival association, aOR 3.18 (95% CI 1.35-7.50). CONCLUSIONS:Hypocapnia and hypercapnia occurred frequently after initiation of mechanical ventilation. Higher PaCO2 levels were associated with increased survival. These data provide rationale for a trial examining the optimal PaCO2 in the critically ill.
Authors: Andrés Esteban; Antonio Anzueto; Fernando Frutos; Inmaculada Alía; Laurent Brochard; Thomas E Stewart; Salvador Benito; Scott K Epstein; Carlos Apezteguía; Peter Nightingale; Alejandro C Arroliga; Martin J Tobin Journal: JAMA Date: 2002-01-16 Impact factor: 56.272
Authors: J G Laffey; M Tanaka; D Engelberts; X Luo; S Yuan; A K Tanswell; M Post; T Lindsay; B P Kavanagh Journal: Am J Respir Crit Care Med Date: 2000-12 Impact factor: 21.405
Authors: Antoine G Schneider; Glenn M Eastwood; Rinaldo Bellomo; Michael Bailey; Miklos Lipcsey; David Pilcher; Paul Young; Peter Stow; John Santamaria; Edward Stachowski; Satoshi Suzuki; Nicholas C Woinarski; Janine Pilcher Journal: Resuscitation Date: 2013-02-27 Impact factor: 5.262
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Scott E Sinclair; David A Kregenow; Wayne J E Lamm; Ian R Starr; Emil Y Chi; Michael P Hlastala Journal: Am J Respir Crit Care Med Date: 2002-08-01 Impact factor: 21.405
Authors: Ary Serpa Neto; Carmen S V Barbas; Fabienne D Simonis; Antonio Artigas-Raventós; Jaume Canet; Rogier M Determann; James Anstey; Goran Hedenstierna; Sabrine N T Hemmes; Greet Hermans; Michael Hiesmayr; Markus W Hollmann; Samir Jaber; Ignacio Martin-Loeches; Gary H Mills; Rupert M Pearse; Christian Putensen; Werner Schmid; Paolo Severgnini; Roger Smith; Tanja A Treschan; Edda M Tschernko; Marcos F V Melo; Hermann Wrigge; Marcelo Gama de Abreu; Paolo Pelosi; Marcus J Schultz Journal: Lancet Respir Med Date: 2016-10-04 Impact factor: 30.700
Authors: Ciara E Keogh; Carsten C Scholz; Javier Rodriguez; Andrew C Selfridge; Alexander von Kriegsheim; Eoin P Cummins Journal: J Biol Chem Date: 2017-05-15 Impact factor: 5.157
Authors: Brian W Roberts; Nicholas M Mohr; Enyo Ablordeppey; Anne M Drewry; Ian T Ferguson; Stephen Trzeciak; Marin H Kollef; Brian M Fuller Journal: Crit Care Med Date: 2018-03 Impact factor: 7.598